Cargando…

Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy

PURPOSE: To improve the preoperative prediction of the outcomes of patients diagnosed with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU), we explored various preoperative laboratory factors and established a prognostic risk stratification method. PATIENTS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zihan, Xie, Shangxun, Feng, Baofu, Zhang, Shiwei, Sun, Yifan, Guo, Hongqian, Yang, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526009/
https://www.ncbi.nlm.nih.gov/pubmed/33061597
http://dx.doi.org/10.2147/CMAR.S274332
_version_ 1783588791287545856
author Zhao, Zihan
Xie, Shangxun
Feng, Baofu
Zhang, Shiwei
Sun, Yifan
Guo, Hongqian
Yang, Rong
author_facet Zhao, Zihan
Xie, Shangxun
Feng, Baofu
Zhang, Shiwei
Sun, Yifan
Guo, Hongqian
Yang, Rong
author_sort Zhao, Zihan
collection PubMed
description PURPOSE: To improve the preoperative prediction of the outcomes of patients diagnosed with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU), we explored various preoperative laboratory factors and established a prognostic risk stratification method. PATIENTS AND METHODS: We retrospectively reviewed 232 UTUC patients who underwent RNU from September 2010 to October 2019 and analyzed their comprehensive clinicopathologic data and preoperative blood-based biomarkers. Kaplan–Meier analysis, receiver-operating characteristic (ROC) curves analysis and Cox regression analysis were performed to assess the relationship between these factors and the prognosis. RESULTS: The median follow-up and age were 24 months and 68.5 years, respectively. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR > 3.44) and decreased albumin (ALB < 39.8 g/L) were negatively correlated with progression-free survival (PFS), cancer-specific survival (CSS) and overall survival (OS) in both univariate and multivariate analyses. Patients were sorted into three groups based on their NLR and ALB: the low-risk group (neither elevated NLR nor decreased ALB), intermediate-risk group (either elevated NLR or decreased ALB) and high-risk group (elevated NLR and decreased ALB). Their 5-year PFS rates were 77.8%, 52.6% and 32.3%; their 5-year CSS rates were 97.7%, 71.4% and 32.9%; and their 5-year OS rates were 92.7%, 70.4% and 29.2%, respectively (all P < 0.0001). ROC curves analysis showed that NLR plus ALB had a more accurate prognostic value (P < 0.05). CONCLUSION: Preoperative risk classification using NLR and ALB was identified as an independent prognostic factor for patients with UTUC. The combination of NLR and ALB may help to determine the most appropriate treatment options before RNU.
format Online
Article
Text
id pubmed-7526009
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-75260092020-10-14 Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy Zhao, Zihan Xie, Shangxun Feng, Baofu Zhang, Shiwei Sun, Yifan Guo, Hongqian Yang, Rong Cancer Manag Res Original Research PURPOSE: To improve the preoperative prediction of the outcomes of patients diagnosed with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU), we explored various preoperative laboratory factors and established a prognostic risk stratification method. PATIENTS AND METHODS: We retrospectively reviewed 232 UTUC patients who underwent RNU from September 2010 to October 2019 and analyzed their comprehensive clinicopathologic data and preoperative blood-based biomarkers. Kaplan–Meier analysis, receiver-operating characteristic (ROC) curves analysis and Cox regression analysis were performed to assess the relationship between these factors and the prognosis. RESULTS: The median follow-up and age were 24 months and 68.5 years, respectively. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR > 3.44) and decreased albumin (ALB < 39.8 g/L) were negatively correlated with progression-free survival (PFS), cancer-specific survival (CSS) and overall survival (OS) in both univariate and multivariate analyses. Patients were sorted into three groups based on their NLR and ALB: the low-risk group (neither elevated NLR nor decreased ALB), intermediate-risk group (either elevated NLR or decreased ALB) and high-risk group (elevated NLR and decreased ALB). Their 5-year PFS rates were 77.8%, 52.6% and 32.3%; their 5-year CSS rates were 97.7%, 71.4% and 32.9%; and their 5-year OS rates were 92.7%, 70.4% and 29.2%, respectively (all P < 0.0001). ROC curves analysis showed that NLR plus ALB had a more accurate prognostic value (P < 0.05). CONCLUSION: Preoperative risk classification using NLR and ALB was identified as an independent prognostic factor for patients with UTUC. The combination of NLR and ALB may help to determine the most appropriate treatment options before RNU. Dove 2020-09-25 /pmc/articles/PMC7526009/ /pubmed/33061597 http://dx.doi.org/10.2147/CMAR.S274332 Text en © 2020 Zhao et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Zhao, Zihan
Xie, Shangxun
Feng, Baofu
Zhang, Shiwei
Sun, Yifan
Guo, Hongqian
Yang, Rong
Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
title Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
title_full Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
title_fullStr Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
title_full_unstemmed Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
title_short Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
title_sort preoperative risk classification using neutrophil-to-lymphocyte ratio and albumin for upper tract urothelial carcinoma treated with radical nephroureterectomy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526009/
https://www.ncbi.nlm.nih.gov/pubmed/33061597
http://dx.doi.org/10.2147/CMAR.S274332
work_keys_str_mv AT zhaozihan preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy
AT xieshangxun preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy
AT fengbaofu preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy
AT zhangshiwei preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy
AT sunyifan preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy
AT guohongqian preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy
AT yangrong preoperativeriskclassificationusingneutrophiltolymphocyteratioandalbuminforuppertracturothelialcarcinomatreatedwithradicalnephroureterectomy